CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 24 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 2,631.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $41,000 | -88.4% | 58,158 | -50.0% | 0.01% | -84.8% |
Q3 2014 | $354,000 | -0.8% | 116,316 | 0.0% | 0.03% | +17.9% |
Q2 2014 | $357,000 | -16.6% | 116,316 | 0.0% | 0.03% | -3.4% |
Q1 2014 | $428,000 | -8.5% | 116,316 | 0.0% | 0.03% | -6.5% |
Q4 2013 | $468,000 | -5.6% | 116,316 | 0.0% | 0.03% | -41.5% |
Q3 2013 | $496,000 | +44.6% | 116,316 | 0.0% | 0.05% | +51.4% |
Q2 2013 | $343,000 | – | 116,316 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 2,356,091 | $1,202,000 | 0.05% |
VANGUARD GROUP INC | 6,177,466 | $156,921,000 | 0.01% |
SHUFRO ROSE & CO LLC | 17,500 | $8,000 | 0.00% |
LEAVELL INVESTMENT MANAGEMENT, INC. | 12,000 | $6,000 | 0.00% |
PACIFIC GLOBAL INVESTMENT MANAGEMENT CO | 10,000 | $5,000 | 0.00% |
Glassman Wealth Services | 2,197 | $1,000 | 0.00% |
Krilogy Financial LLC | 600 | $1,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 5,856 | $3,000 | 0.00% |
NORTHERN TRUST CORP | 33,166 | $17,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 86,435 | $44,000 | 0.00% |